Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: EPAM stock price vs HRMY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HRMY's multiple
Needs HRMY P/E.
Implied fair value · at EPAM's multiple
Needs EPAM P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EPAM FY 2025 (ended Dec 31, 2025) · HRMY FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
EPAM SYSTEMS, INC. · implied price per share
Bear
$84.43
Base
$99.33
Bull
$114.23
HARMONY BIOSCIENCES HOLDINGS, INC. · implied price per share
Bear
$42.25
Base
$49.71
Bull
$57.16
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.01x
0.19x
Net debt / EBITDA
Leverage against operating earnings
-1.89x
-2.20x
Cash and equivalents
Liquid reserves on the balance sheet
$1.30B
$775.34M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Accenture plc
EPAM vs ACN
COGNIZANT TECHNOLOGY SOLUTIONS CORP
EPAM vs CTSH
GRID DYNAMICS HOLDINGS, INC.
EPAM vs GDYN
Endava plc
EPAM vs DAVA
Jazz Pharmaceuticals plc
EPAM vs JAZZ
SUPERNUS PHARMACEUTICALS, INC.
EPAM vs SUPN
Intra-Cellular Therapies, Inc.
EPAM vs ITCI
ACADIA PHARMACEUTICALS INC
EPAM vs ACAD
Vanda Pharmaceuticals Inc.
EPAM vs VNDA
LivaNova PLC
EPAM vs LIVN
$27.90M
$163.66M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote
Live quote
